Tagged: nanotechnology
25 results
Nawah Scientific
Nawah Scientific is an Egyptian deep-tech company that runs a 'cloud lab' - a network of advanced laboratories that researchers, universities and companies can access remotely by shipping in samples and receiving results online. Founded in Cairo in 2015 by Omar Shoukry Sakr, it consolidates expensive scientific equipment in central facilities so clients across life sciences, pharma, food and agriculture can run analytical testing without owning the instruments. After a decade it has tested more than a million samples for clients in 30+ countries and, in December 2025, closed a $23 million Series A to build a regional research center in Rwanda and double lab capacity in Egypt and Saudi Arabia.
Nabaco® Inc.
Nabaco® Inc. is a San Marcos, Texas materials-science company that makes self-assembling natural barrier coatings to keep fresh produce fresh longer and cut food waste. Its flagship product, NatuWrap®, is a GRAS-listed edible coating built from clay and plant extracts that locks moisture in while keeping oxygen and microbes out - applied by spraying, dipping or brushing at a fraction of the cost of rival coatings. Founded on nanotechnology research from Texas State University, Nabaco is expanding into pre-harvest crop protection (Envello) and post-harvest processing aids (Vanterra) to protect food across the whole supply chain.
Nanosys
Nanosys is a Silicon Valley materials company, founded in 2001 in Milpitas, California, that makes quantum dots - man-made semiconductor crystals 2 to 8 nanometers across that convert light into precisely tuned, saturated color. Its Quantum Dot Enhancement Film (QDEF) helped bring wide-color-gamut displays to mass market, and its materials have shipped in more than 70 million televisions, monitors, tablets and phones. Nanosys holds one of the largest quantum dot patent portfolios in the world and is developing NanoLED (QDEL), a self-emissive display technology in which quantum dots make their own light. In September 2023 its quantum dot business was acquired by Japan's Shoei Chemical, which now operates the Nanosys brand and its Milpitas R&D labs.
Flashpoint Therapeutics
Flashpoint Therapeutics is a clinical-stage biotech spun out of Chad Mirkin's nanotechnology lab at Northwestern University, developing 'structural nanomedicines' - drugs whose potency comes not from new molecules but from how existing therapeutic components are arranged at the nanoscale. By co-delivering RNA, DNA, peptide and CRISPR payloads to individual cells with precise stoichiometry and synchronized activation, the company reports it can turn conventionally ineffective drug components into curative therapies, with early data showing dramatically stronger immune activation and tumor killing. Founded by Adam Margolin and backed by a $10M seed round led by Riyadh-based Beta Lab plus a $50M KAIMRC partnership, Flashpoint is advancing its lead immuno-oncology candidate FLASH-001 through the clinic.
Geoffrey von Maltzahn
Geoffrey von Maltzahn is the co-founder and CEO of Lila Sciences, a Cambridge company building what it calls scientific superintelligence: AI plus robotic labs that run the scientific method autonomously. A general partner at Flagship Pioneering, he has founded or co-founded a string of companies including Generate:Biomedicines, Tessera Therapeutics, Indigo Agriculture, Sana Biotechnology, Seres Therapeutics and Quotient Therapeutics, which together carry more than $10 billion in market value. He holds a PhD from the Harvard-MIT Division of Health Sciences and Technology and is named on more than 200 patents.
Adam Margolin
Adam Margolin is a computational biologist turned biotech founder who co-founded Flashpoint Therapeutics, a clinical-stage company engineering spherical-nucleic-acid nanomedicines that aim to turn weak cancer therapies into curative ones. After a 20-year academic career that took him from Wharton and Wall Street to running the #3-ranked genetics department in the country at Mount Sinai, and a stint as a Venture Partner at Khosla Ventures, he teamed with Northwestern nanotech pioneer Chad Mirkin to build Flashpoint. He led the company as founding CEO through a $10M seed round before handing the chief executive role to biotech veteran Barry Labinger in 2025. His mission is deeply personal: his mother died of cancer when he was three.
Brendan Smith
Brendan Smith is the co-founder and CEO of SiTration, an MIT spinout commercializing a tunable silicon membrane that recovers critical metals like copper, cobalt, nickel and lithium from mining waste and spent batteries without the mountains of chemicals the old way demands. A materials scientist who came to MIT from Canada in 2013, he turned a desalination-lab discovery into a venture-backed company that has raised roughly $14.4 million and partnered with mining giant Rio Tinto. He runs the company from a 11,000-square-foot pilot facility in Watertown, Massachusetts.
Murari Ramkumar
Murari Ramkumar is the founder and CEO of Vimano, a deeptech materials startup building PFAS-free, ion-conductive membranes for flow batteries, green-hydrogen electrolyzers and fuel cells. A materials scientist trained at NITK Surathkal and the University of Pennsylvania, he co-founded the company in 2019 with Dr. Nagesh Kini and is chasing an audacious goal: to put a Vimano membrane inside one of every two large-scale energy storage devices, electrolyzers and fuel cells on the planet. In 2025 Vimano raised roughly $2.9 million in seed funding led by Ankur Capital.
Shivang Dave
Shivang R. Dave is the co-founder and CEO of PlenOptika, a Cambridge, Massachusetts medical-device company behind QuickSee, a handheld autorefractor that measures eyeglass prescriptions in about 10 seconds using wavefront aberrometry. A bioengineer with a PhD in bioengineering and nanotechnology, Dave co-invented the device during the Madrid-MIT M+Vision fellowship and has grown PlenOptika from a four-fellow research team into an international company whose technology has helped correct vision for over 7 million people across 60+ countries, especially in low-resource settings.
Avisi Technologies
Avisi Technologies is a clinical-stage ophthalmic medical device company building VisiPlate, an ultrathin, nanotechnology-enabled aqueous shunt that drains excess fluid from the eye to lower pressure in glaucoma patients. Spun out of the University of Pennsylvania's Y-Prize program in 2017, the company is advancing VisiPlate through the FDA-cleared SAPPHIRE pivotal trial and has raised roughly $21.7M to date, including a $10.7M Series A in February 2026.
Boston Micro Fabrication (BMF)
Boston Micro Fabrication (BMF) builds 3D printers that work at a scale most machines can't reach - resolutions down to 2 microns with tolerances of about plus or minus 10 microns. Its microArch printers use a proprietary process called Projection Micro Stereolithography (PuSL) to make tiny, complex parts for medical devices, microfluidics, optics, connectors and semiconductor packaging. Founded in 2016 and headquartered in Maynard, Massachusetts, BMF has placed machines with more than 2,000 customers across roughly 35 countries.
DUST Identity
DUST Identity authenticates physical objects with a thin coat of engineered diamond dust. Each randomly oriented constellation of microscopic diamonds forms a fingerprint that cannot be copied, and that fingerprint is bound to a tamper-evident digital record. The result is an unbroken chain of trust from raw material to final delivery, used across aerospace, defense, electronics, luxury goods, and sports memorabilia.
Gamma Alloys Inc
Gamma Alloys is a Santa Clarita, California advanced-materials company that reinforces aluminum with homogeneously distributed nano-ceramic particles to create metal matrix composites that are stiffer, stronger, more wear-resistant and stable across a wider temperature range than conventional aluminum. Its materials ship as wrought stock (bar, tube, plate), additive powders and additive wire for metal 3D printing, and are aimed at aerospace, defense, automotive, motorsports and even luxury goods. Founded in 2008 and led by CEO Mark Sommer, the company drew an investment from Boeing HorizonX Ventures in 2017 and partners with precision manufacturer Del West USA.
Nuovo Film Inc.
Nuovo Film Inc. is a Silicon Valley advanced-materials company that develops, manufactures, and markets silver nanowire (AgNW) materials under its patented Crystode brand. Its high-precision roll-to-roll coated transparent conductive films replace brittle, indium-based ITO with a flexible, low-resistance, high-transparency alternative used in touch screens, foldable displays, photovoltaics, energy storage, and electric vehicles. Backed by Intel Capital and holding more than 180 patents worldwide, Nuovo Film operates one of the largest silver nanowire production lines in the industry and supplies touch modules to global brands.
John Kawola
John Kawola is a 3D printing industry veteran who has spent nearly three decades turning niche additive-manufacturing technologies into real businesses. He led Z Corporation through the dawn of full-color 3D printing, ran a farm-and-warehouse robotics company, built Ultimaker's North American footprint, and then took the helm of Boston Micro Fabrication (BMF), the company making 3D printers that resolve features down to two microns - smaller than a human hair. In 2025 he handed off the CEO role at BMF to become a strategic advisor.
Kai Jiang
Kai Jiang is the CEO of Nuovo Film Inc., a Silicon Valley materials company that turns silver nanowires into the transparent conductive film behind touchscreens, foldable displays, and large-area interactive panels. Under his watch the company has shipped more than 2.3 million square meters of conductive film, holds 180+ patents worldwide, and claims roughly 60% of the global silver-nanowire market. A Stanford-educated operator with a McKinsey and semiconductor background, Jiang runs a business that is invisible by design: its product is the layer you touch but never see.
Mark Sommer
Mark Sommer is the founder and CEO of Gamma Alloys, a Santa Clarita-based materials company that 'decorates' metal powders with ceramic nanoparticles to make aluminum strong enough to 3D print into aerospace and automotive parts. He simultaneously leads Del West Engineering, the Formula 1 world's go-to maker of titanium valves and lightweight valvetrain components. Backed by Boeing HorizonX, his bet is that of the roughly 5,500 industrial alloys in use, only a few dozen work with 3D printers today, and Gamma's nano-ceramic process can unlock the rest.
Ophir Gaathon
Ophir Gaathon is the co-founder and CEO of DUST Identity, a Massachusetts deep-tech company that sprinkles microscopic, industrial diamond dust onto physical objects to give them an unclonable fingerprint. A Columbia-trained applied physicist who once chased the quantum properties of diamonds for computing, he turned that research into an identity layer for the physical world, used across defense, aerospace, automotive and luxury supply chains. Backed by Kleiner Perkins, Airbus Ventures, Lockheed Martin and Castle Island Ventures, his company has raised more than $50M and works on problems originally posed by DARPA.
Numat
Numat is a Chicago-based advanced-materials company and the first to commercialize metal-organic frameworks (MOFs) at industrial scale. Its molecularly engineered, programmable 'sponges' capture, store, and separate hazardous chemicals for semiconductor, defense, and energy customers, reducing the impact of chemical products and processes on human health and the environment.
Axoft
Axoft is a Cambridge, Massachusetts neurotechnology company building implantable brain-computer interfaces (iBCIs) out of Fleuron, a proprietary material it claims is up to 10,000x softer than the polyimide used in conventional brain implants. By making electronics roughly as soft as brain tissue, Axoft aims to keep thousands of sensors in stable contact with single neurons for years instead of months - reducing scarring and signal loss - to diagnose and eventually treat disorders of consciousness, paralysis, and other neurological conditions. A Harvard spinout founded in 2021, it raised an oversubscribed $55M Series A in April 2026 and has run first-in-human studies in 11+ patients worldwide.
Rui Jing
Rui Jing Jiang is the Founder and CEO of Avisi Technologies, a Redwood City-based clinical-stage medical device company developing VisiPlate, the world's thinnest freestanding ophthalmic implant for treating glaucoma. Built on University of Pennsylvania nanotechnology, VisiPlate is a multichannel aqueous shunt composed of alumina and Parylene-C that is 20 times thinner than a human hair. Rui Jing co-founded the company in 2017 as a junior at Penn's Wharton School, won the $100,000 President's Innovation Prize in 2018, secured FDA Investigational Device Exemption approval in October 2025 for the US SAPPHIRE trial, and closed a $10.7M Series A in February 2026 to advance pivotal clinical development.
Michael McShane
Michael (Mike) J. McShane is a biomedical engineer who has spent close to 25 years trying to put readable chemistry under the skin. As James J. Cain Professor II and head of the Department of Biomedical Engineering at Texas A&M University, he builds injectable, biomaterials-based optical biosensors - often called 'smart tattoos' - that glow in response to glucose, oxygen and other body chemistries so doctors can monitor patients continuously and minimally invasively. A Fellow of IEEE, SPIE, BMES and AIMBE, past president of the IEEE Sensors Council and founding chair of the IEEE BioSensors conference, he won the 2012 NIH Director's Transformative Research Award and the 2023 IEEE Sensors Council Technical Achievement Award.
Martin Devenney
Dr. Martin Devenney is the CEO of Nanosys, the world's leading quantum dot technology company now part of Shoei Chemical. A chemist-turned-manufacturer with a PhD from Queen's University Belfast and over 35 patents, he spent eight years scaling Nanosys's quantum dot production from lab curiosity to the backbone of more than 1,000 unique display products across 70 million consumer devices. Named CEO in May 2023, he then engineered the company's acquisition by Japanese chemical giant Shoei Chemical in September 2023, positioning Nanosys to lead the next generation of display technologies including NanoLED, QD-OLED, and automotive quantum dot applications.
Olgica Bakajin
Olgica Bakajin is the CEO and Founder of Porifera Inc., a San Leandro, California-based company pioneering forward osmosis membrane technology for the food, beverage, and industrial water sectors. A physicist by training - B.A. from the University of Chicago and Ph.D. from Princeton - she spent nearly a decade at Lawrence Livermore National Laboratory developing carbon nanotube membranes that move water 1,000x faster than conventional materials. Her 2006 Science paper on carbon nanotube desalination became the most-cited chemistry article in the journal. In 2009 she spun Porifera out of LLNL, and the company now serves 100+ customers across 20+ countries, helping breweries, coffee roasters, and winemakers concentrate their products without heat, preserving flavor, aroma, and nutrients while slashing energy use by up to 80%.
Steve Jurvetson
Steve Jurvetson is a legendary Silicon Valley venture capitalist and co-founder of Future Ventures, best known for coining the term 'viral marketing,' backing Hotmail, SpaceX, and Tesla from their earliest days, and bringing a scientist's obsession to everything from model rockets to nanotechnology. After two decades at Draper Fisher Jurvetson managing over $6 billion, he launched Future Ventures in 2018 with a patient, 15-year fund structure focused on deep tech, AI, space, and synthetic biology. A triple Stanford alumnus who finished his EE degree in 2.5 years at the top of his class, Jurvetson is as likely to be found photographing rocket launches on his Flickr account as sitting on SpaceX's board.